ArticleHepatology international2026
Periportal hepatocytes secret SAA1 to recruit MoKCs and interactions through CADM1 signaling to promote MASLD.
Article in Hepatology international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundIn non-alcoholic steatohepatitis, there is a compensatory increase in monocyte-derived Kupffer cells (MoKCs) due to the loss of resident Kupffer cells. However, the mechanisms behind MoKCs recruitment and their impact on steatohepatitis development remain unclear. We aimed to elucidate the contribution of continuously recruited MoKCs and the interaction between MoKCs and other cells in macrophage-mediated metabolic dysfunction associated steatotic liver disease (MASLD) to disease exacerbation.
methodsWe utilized snRNA-seq analysis parallel to characterize the transcriptomes of hepatocytes and non-parenchymal cells (NPCs) in the MASLD progression of steatosis to fibrosis livers in mice and humans, integrating multi-omics analyses among the program. We used spatial transcriptome analysis to discover key functional compartments to recruit MoKCs in MASLD progression. Further performed the critical cytokine validation by genome-wide association analysis combine with genetic risk scores construction in 5,936 individuals. The signal that recruited MoKCs damaging hepatocytes was explored by cell-cell communication analysis and co-culture system.
resultsWe confirmed through difference cytokine screening and spatial transcriptome that serum amyloid A1 (SAA1) is significantly involved in the pathogenesis of MASLD as evidenced by periportal hepatocytes (PPHs) recruiting MoKCs through the secretion of SAA1. The polygenetic risk score also indicated SAA1 significantly increased MASLD risk in UK Biobank cohort. The recruited MoKCs can in turn disrupt liver microenvironment homeostasis through abnormal cell-cell interactions with hepatocytes, endothelial cells (ECs) and hepatic stellate cells (HSCs). Of these, the recruited MoKCs damaging hepatocytes via CADM1 signal was validated through co-culture system.
conclusionThese findings enhance our comprehension of MoKCs recruitment and turnover in humans and mice, emphasizing their critical role in the multiple-hit injury process during MASLD development.
Indexed as
Identifiers
41673374What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.